1. Adams, W. (2003). The myth of patent neutrality: Property, patents, animal rights and animal welfare in commissioner of patents V. President and fellows of Harvard College. Canada Business Law Journal, 39, 181.
2. Beauchamp, T., & Childress, J. (2012, 1979). The principles of biomedical ethics. Oxford and New York: Oxford University Press.
3. Beekman, V., De Bakker, E., Baranzke, H., Baune, Ø., Deblonde, M., Forsberg, E-M., et al. (2006). Ethical bio-technology assessment tools for agriculture and food production. 2006/2.
http://estframe.net/ethical_bio_ta_tools_project/content_2/text_2c81d261-b7a8-43e8-8f1e-d724b43e2ba3/1346076907647/et1_final_report_binnenwerk_59p.pdf
. Accessed 5 Jan 2016.
4. Beyleveld, D. (2000). Regulating morality through patent law. Critique of the EC Directive. Revista De Derecho Y Genoma Humano = Law And The Human Genome Review/Cátedra De Derecho Y Genoma Humano/Fundación BBV-Diputación Foral De Bizkaia, 12, 141–171.
5. Borrás, S., Koutalakis, C., & Wendler, F. (2007). European agencies and input legitimacy: EFSA, EMeA and EPO in the post-delegation phase. Journal of European Integration, 29(5), 583–600.